Abacavir + Lamivudine
Composition
The formulation contains Abacavir 120mg + Lamivudine 60mg Tablet: Contains abacavir 120mg and lamivudine 60mg as the active ingredients.
Indications
HIV infection in pediatric patients
Side effects
Hypersensitivity reactions, nausea, headache
Precautions
Screen for HLA-B*5701 allele due to risk of hypersensitivity
Contraindications
Positive HLA-B*5701 allele, moderate to severe liver impairment
Dosage and administration
Based on weight and clinical condition
Countries
UK, India, Australia
Available Forms
Tablets
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai